Haoxi Health Technology vs Inuvo
HAO and INUV side by side, both in business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HAO and INUV compare
Haoxi Health Technology grew revenue faster over the last twelve months (67.1% versus −62.8% for Inuvo).
Haoxi Health Technology keeps more of each dollar of sales as profit, with a net margin of −17.4% compared with −21.1% at Inuvo.
Haoxi Health Technology scores higher on the StockData Score (4 against 3 for Inuvo), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HAO | INUV |
|---|---|---|
| Size and price | ||
| Market cap | – | $4.6M |
| Share price | $1.81 | $0.277 |
| Change, 1 year | −99.9% | −89.4% |
| Change, 5 years | – | −95.7% |
| Beta (5Y) | – | 1.27 |
| Employees | 30 | 72 |
| StockData Score | ||
| Total score | 4 (better) | 3 |
| Valuation score | 0 | 3 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 2 (better) | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 0.1× |
| P/B | – | 0.7× |
| FCF yield | – | −89.7% |
| Fair value | – | $0.924 |
| Margin of safety | – | 70.0% |
| Growth | ||
| Revenue growth (TTM) | 67.1% (better) | −62.8% |
| Revenue growth, 5Y average | – | 14.1% |
| Net income growth (TTM) | −346% | – |
| EPS growth (TTM) | −111% | – |
| Profitability | ||
| Gross margin | 1.1% | 53.2% (better) |
| Operating margin | −17.6% (better) | −35.4% |
| Net margin | −17.4% (better) | −21.1% |
| FCF margin | – | −11.2% |
| Return on equity | −54.1% (better) | −92.0% |
| Return on invested capital | −79.5% (better) | −111% |
| Financial health | ||
| Debt / equity | 0.09 (better) | 0.98 |
| Interest coverage | −184.3× | – |
| Current ratio | 4.53 (better) | 0.61 |
| Altman Z-score | – | −11.09 |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Buyback yield | – | 0.00% |
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | – | 20.1% |
| Held by insiders | – | 44.8% |
| Insider net buying, 12 months | $800K | – |
| Short interest, % of float | – | 4.2% |
Go deeper
- HAO stock overview
- HAO income statement
- HAO valuation and score
- INUV stock overview
- INUV income statement
- INUV valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.